Peer Review History
Original SubmissionOctober 20, 2022 |
---|
PONE-D-22-28987Visual feedback manipulation in virtual reality to influence pain-free range of motion. Are people with pain who are fearful of movement more susceptible?PLOS ONE Dear Dr. Kragting, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mariella Pazzaglia Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. Additional Editor Comments: I have invited comments from experts from your research domain. As you will see, the paper is interesting, but design and method would need to be addressed/explained carefully. Taken altogether, let me invite you to prepare a revision that addresses the issues, together with a cover letter explaining how you did so. My plan is to resend the revision to the present referees. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper, the authors study how the manipulation of visual experience through the use of virtual reality can affect the perception of pain due to movement in participants with non-specific neck pain. The main result of the study is to have identified a greater amplitude of pain-free movement when visual manipulation reduces the perceived rotation angle compared to when it is increased. The effect reached significance only within the group without kinesiophobia. The article is written in appropriate and easily understandable language. Data analysis, the process is fully described and seems to have been conducted appropriately in relation to the characteristics of the research. An interesting aspect is also the easy transportability in the clinical practice of these types of procedures. However, the literature on these aspects is more extensive than perhaps transpires from what is presented in the introduction and could benefit from slight enrichment. At the discretion of the authors, I believe that some passages could benefit from brief clarification or elaboration. The statements in the abstract should be made more explicit and understandable. In particular, results and discussion could clearly report not only that effects have been identified but also in what direction these are going (i.e. effects on participants’ painless movements). 56 The concept of "non-specific neck pain" should be better defined. 66-67 and Fig.1A. The authors refer to another study, but a figure in reference (6) depicts the same subjects with the same experimental setup with the same caption as fig 1A, this may be confusing. Please clarify in the text, photo/picture caption, or both if necessary. The authors in their manuscript provide all the necessary information. However, for the convenience of the reader, it would seem to me to be useful to indicate in the participants section some basic info (which the authors actually include in the first few lines of the results) in order to understand with more immediacy numerosity and demographic characteristics of the participants. L91 Please be a little clearer about the exclusion criterion. Is the problem in vision or possible problems related to wearing an HMD while wearing glasses? Was corrected to normal vision using contact lenses was ok? Genders are differently represented, and in the rest of the manuscript, there is no mention of gender except in the table. Please include explicitly in the text, either in the participant section or in the results and/or discussion, the rationale for this choice and some consideration of the role of this variable in the study. 167-170 Appropriate pilot study was used to test the recognition effect of manipulation on specific stimuli. Although in non-identical procedures, visual perspective manipulation via virtual reality is nonetheless present in the literature, and providing one or two insights might be appropriate for the manuscript and useful to the reader. 186 It might be interesting for the reader to have one or two examples of environments (e.g., 1 natural and 1 artificial) available directly in the manuscript from among the supplementary materials. Also, about the environments used, it seems to me that the choice of the types of such environments is not discussed except to avoid possible learning effects and memorization of visual references. Two environments are natural and very bright, while four are artificial and dark. The literature addresses these types of differences from numerous perspectives, however, given the short duration of the exposures and the type of task, it may not be of particular relevance. However, it would be appropriate to include in the manuscript, also in the discussion (around lines 344-347 would seem appropriate to me), some brief consideration and reference regarding this choice and the possible implications of the characteristic qualities of the environment. Reviewer #2: General comment - The aim of this study is clinically relevant and it will be of interest to clinicians. However, to be even more clinically and scientifically relevant, the results must be reinterpreted according to current guidelines in terms of p values. Line 2 – “Are people with non-specific neck pain”? Abstract Line 36 – Specify “people with non-specific neck pain” and add the comparison group (fear vs no fear). Line 37 – Specify the population (e.g., acute, subacute, chronic)? It would be nice to have this specification for the whole manuscript. Line 39 – Replace “impact” with “effect” to be consistent. Line 44 – A p-value > 0.05 does not mean that there is no effect. Actually, the effect is η² = 0.044. This effect is really close to the other one (η² = 0.06) with a p-value < 0.05. I advise you to read the American Statistical Association statement about p-values. It is not recommended to focus on the “statistical significance” (p < 0.05) anymore. Introduction Line 56 – It may be interesting to add a definition of “non-specific neck pain”, because you included traumatic neck pain in the sample and this type of neck pain is not always included in the “non-specific neck pain” population. Line 58 – “that may be perceived as threatening”? Line 66 – Again, it is not right to state that there was no effect only based on p-values. In interpreting the results, we should include the exact p-value, the effect size, and its 95%CI. Furthermore, it should be better to show the effects found in that study and then compare them with the effect found in the other one. If there are differences in effect sizes, it can be very interesting to find some possible explanations. Lines 74-75 – “Individuals who are not fearful of movement may unlearn the association made between movement and pain, allowing pain to extinguish”. This is a strong hypothesis, because it says that pain can be extinguished only because of the unlearned association. However, not all people with non-specific neck pain have fear of movement, but they still suffer from pain. Lines 78-79 - Maybe replace with "the aim for the current study was to evaluate whether the effect of visual feedback manipulation is greater in people with non-specific neck pain that are fearful of movement, compared to people with non-specific neck pain that are not»? Or something like that. However, in both cases, your hypothesis seems to be a superiority one (“more susceptible”). It will have an impact on the statistical hypothesis and testing used. Methods and materials General comment – The manuscript does not follow best practices for reporting. In addition, there is no registered protocol of the experiment. General comment - You separated people with fear into two subgroups (TSK and FABQ-pa). I understand, but as you said earlier, these are two closely related constructs of fear. So why did you not combine them together into one group (“fearful people”)? And after that, it can be divided into two subgroups to see if there are some differences in the effect size. Line 84 – What was the sampling method used? Was it probabilistic (random) or non-probabilistic (e.g., convenience, snowballing)? It should be specified as it impacts the generalizability of the findings. Line 95 – “Based on an expected effect size of ηp² = 0.145 (i.e., 0.29/2)”. What is the basis for that? Why did you divide the effect by 2? If there is no specific reason, you should specified that it was arbitrary. Line 110 – “motion sickness was evaluated”. Why? What information did it provide? Is it related to the purpose of the study? Line 132 – Please add a reference for the cut-off score of FABQ-pa. Line 143 – I don’t understand why this outcome is assessed. I don’t think there is a link with the purpose of the study. Is motion sickness susceptible to influence the pain-free ROM or another outcome? If yes, it should be specified in the introduction. Line 184 – Please specify the method of randomization. Line 186 – There are six environments. So, one environment per repetition for each condition? It is not clear. Line 194 – “different”. Here you say "different" (equivalence or not), but the aim of the study was to evaluate whether the effect was greater in fearful subjects, to see if they are more susceptible (superiority or not). The hypotheses are not the same, as well as the type of p-value (one-sided or two-sided). Line 194 - It is stated that there are only 2 groups (with fear and without fear), however in the analyses there are 3 groups (without fear, fear with TSK, fear with FABQ-pa). It needs to be clarified. Line 195 – Why is the absolute data analysis not included in the manuscript? Line 202 - Thresholds are not clearly distinct, there are overlaps (e.g., 0.059 is small or medium?). Line 205 – “two subgroups”. In total there are 3 subgroups. Maybe you want to say that there are 2 subgroups per analysis? If yes, please specify. Results General comment – Results need to be reinterpreted according to the American Statistical Association statement on p-values. We should not use the “statistical significance” (p<0.05) to conclude if there is an effect or not. Results should be described with exact p-values, effect size, and its 95%CI. Adding the relative changes of range of motion would be great, as it allows readers to better understand the changes observed and to judge if they may be of clinical relevance (effect sizes in terms of η² might be difficult to interpret for clinicians). Line 218 – In the methods it is stated that 40 subjects were needed (according to the sample size calculation, 20 per group). However, 75 people participated. Why? Lines 221 to 223 – If I understand, you included people with fear of physical activity into the "no fear" group (compared to TSK), and you included people with kinesiophobia into the "no fear" group (compared to FABQ). If yes, I am not sure this is right because they are fearful in both cases. I don't think they can be considered as "no fearful". Including people with kinesiophobia or fear of physical activity in the “no fear” group may induce biases in the results as they are fearful in both cases. So, you compared “fearful” people with “fearful + no fearful” people. Line 223 – “10 participants had fear according to both questionnaires”. So, these participants were included twice in the analyses? Once for TSK and once for FABQ-pa? Line 225 – “no differences”. Based on what? If you refer to the p-values, please indicate the exact p-value. However, it would be interesting to add the values of age and duration of neck pain for both groups. As mentioned earlier, the p-value alone is not sufficient to state that there is a difference or not. Lines 226-227 – “more disabled, scored higher on pain intensity and was more limited in the pain-free range of rotation”. Based on what? If you refer to the p-values, please indicate the exact p-value for each comparison. However, it would be interesting to add the values of pain intensity, disability, and ROM for both groups. As mentioned earlier, the p-value alone is not sufficient to state that there is a difference or not. Line 230 – What about people with fear of physical activity? Line 243 – “Numeric” rather than “Nummeric”. Line 255 – It is not recommended to use the “statistical significance” anymore. Please read the American Statistical Association statement on p-values. It would be great to show the relative change in range of motion and its 95%CI where appropriate. In addition of the effect size, it gives a better idea of the effect (it is well done in the S3 appendix). Interpreting these effects as clinically relevant or not would also be a good idea. Lines 263 to 266 – Do not use statistical significance. For example, you could say that “differences in range of motion between the overstated gain and the control condition (p=0.051, ղ2=0.052), and between the understated gain and the control condition (p=0.077, ղ2=0.044) were a bit smaller than the effect found between the understated and the overstated conditions”. Or something like that, to focus not on statistical significance but on effect sizes. Adding a 95%CI for effect sizes would also be good. Line 272 – “conflicting” rather than “conflciting”. Why is it “conflicting”? Is it because the p-value is superior to 0.05? Line 280 – “Median” rather than “mean”? Line 283 – You indicated 75 participants before, now it is 76. Please correct. Line 287 – I still don’t understand why this outcome is evaluated and its usefulness in this study. Discussion Line 303 – Replace “pain-related” by “pain-free” to be consistent. Lines 306-307 – Can these factors play a role in the effects observed? If yes, it should be discussed. You do not mention these factors as potential confounders in the differences in the effects observed. Lines 321 to 325 – First, the absolute range of motion scores are detailed in the S3 Appendix, however I am not sure that readers will look at it. These scores are discussed here without any specific reason, as you mentioned earlier in the manuscript that you would use the relative data (to account for differences in the overall neck range of motion). Why do you discuss the absolute changes and not the relative ones? In the manuscript, you only show the analyses for the relative data, but in the discussion, you only mention the absolute data. It is not clear. Second, these differences in absolute range of motion are on the order of 4-5 degrees for the total range of motion in rotation. Is it clinically relevant? I think it would be good to specify the clinical relevance of these findings. Line 338 – Why is it convincing? What is your basis for that? Line 343 - Again, "no effect" means that the effect size equals 0. Was it the case? Or just a p-value > 0.05? Lines 367-368 – The conclusion is a bit too ambitious. I advise you to interpret according to the results. Maybe something like "In people with non-specific neck pain, those with fear of movement may be more susceptible for the effect of visual feedback manipulation than people without fear of movement. Because the effect sizes are small to medium and because of the limitations mentioned, the results should be interpreted with caution”. Results should also be interpreted according to the sample characteristics (more females, middle-aged people, duration of neck pain, mean pain intensity, disability). Please revise it in the abstract too. S3 Appendix Line 4 - The Kolmogorov-Smirnov test is used to assess normality. However, in the manuscript it is stated that normality is assessed via Q-Q plots and histograms. Why is it different here? Lines 13 to 17 – Interaction effect was present in both cases, however it was no “significant” based on the “p<0.05” threshold. Please see the American Statistical Association statement about p-values. These results need to be reinterpreted. Lines 13 to 30 – Are these mean changes clinically relevant? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-22-28987R1Visual feedback manipulation in virtual reality to influence pain-free range of motion. Are people with non-specific neck pain who are fearful of movement more susceptible?PLOS ONE Dear Dr. Kragting, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mariella Pazzaglia Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: As you can see, the reviewer thinks your paper is potentially publishable but that some changes would be required. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Introduction Lines 80-81 – The authors said “to emphasize that it is an assumption, we have made the following adjustment ‘The underlying assumption is that individuals who are not fearful of movement may unlearn the association made between movement and pain, allowing pain to extinguish’”, in relation to the comment number 9 (first revision). It's clearer that this is a hypothesis. However, my comment was more about the "allowing pain to extinguish" part. By saying this, the authors are assuming that the association between movement and pain is the only factor that determines the presence of pain. I'm not so sure about that. I think pain can be reduced, but not necessarily extinguished. I would suggest being more nuanced in the sentence and saying, for example, "allowing pain to be reduced". Methods and materials General comment – The authors have confirmed that they have followed reporting guidelines, but these are not mentioned in the manuscript. Please specify which reporting guidelines were followed in this manuscript. Line 91 – I think that the first part of the sentence should be placed at the beginning of the results. The number of subjects is also written at line 238, but with different characteristics in brackets. It should be better to combine these two sentences in one (only the number of subjects and their characteristics) to avoid repetition. Lines 119-121 – “Since motion sickness is a common side effect in VR (17), especially in people with neck pain (18), and a possible barrier when considering implementing VR in clinical practice, it was evaluated after the VR-experiment using the short version of the Misery Scale (sMISC)”. Line 131 – “(FABQpa)” rather than “(FABQpa))”. Line 132 – “Cut-off” rather than “cut-of”. Line 212 – To be as complete and transparent as possible, I would suggest specifying that you will present results using exact p-values, the effect estimate and its 95%CI. Avoiding the use of the threshold "p<0.05" is not yet widespread in musculoskeletal research, so readers may be confused and wonder why you don't specify whether the results are statistically significant or not, if this is not stated here. Results Line 238 – My comment was: “In the methods it is stated that 40 subjects were needed (according to the sample size calculation, 20 per group). However, 75 people participated. Why?”. Authors responded: “The subgroups (fear/no fear) were not equally distributed. We continued to enroll participants until we could include about 20 people with fear of movement.”. I understand, but why didn't you keep the first 20 subjects with no fear of movement and only continue to enroll subjects with fear of movement? In any case, it's already been done. So, I suggest clarifying in the manuscript what you mentioned above, so that the reader is not confused about the difference between the sample size calculation and the final sample size. Lines 244-245 – It says "In both groups" at the beginning of the sentence, but don't you mean "In both analyses"? I think it is not clear enough, because you have two fearful subgroups. Line 250 – Add “pain-free” before “range of rotation” to be consistent. Line 251 – Add “degrees” after “… with fear of physical activity 106.9 (38.4)”, to be consistent. Table 1 – I don't think it's necessary to specify both sexes. In general, we only specify one sex (female or male), because if we know the numbers for one, we indirectly know the numbers for the other. Line 265 – If you use a specific threshold for significance for these tests, you should specify which one you are using. Lines 281-285 – At the beginning of the sentence (starting with “Contrasts…”) you compare pain free range of motion between the understated condition and the control condition, in fearful people, but in the next part of the sentence it is less clear. Do you talk about overstated versus control condition in fearful and non-fearful people, or do you compare fearful vs non fearful people in both conditions? Line 282 – If you avoid using a specific threshold for statistical significance, it is best to avoid terms like “significantly”. Lines 287-289 – The following part of the sentence is not clear for me: “decreased by 4.5%, 95%CI [-9.0%, 0.0%] (TSK) respectively 6.5%, 95%CI [-9.9%, -3.1%] (FABQpa) in the overstated condition.”. Could you rewrite it more clearly? Line 289 – “This direction of the effect of visual feedback was as expected”. For me, this should be placed in the discussion. Lines 289-290 – I had to reread the previous sentences to understand what the "overall effect" was. I think it would be a good idea to add in brackets what exactly it is. Lines 324-325 – Same comment as for lines 289-290. Lines 340-342 – For completeness and consistency, I would add the number of subjects with each type of symptom, in addition to the percentage (which is done in the previous section). Discussion Line 353 – What do you mean by “susceptibility to visual feedback manipulation”? Maybe “susceptibility for the effect of visual feedback manipulation”? Lines 388-389 – My comment was: “Again, "no effect" means that the effect size equals 0. Was it the case? Or just a p-value > 0.05?”. Authors responded: “In this case we think we can say there is ‘no effect’, as the effect size is small, and the p-value high (p=0.133, ղp2=0.031)”. I don’t agree. To be consistent with the rest of the manuscript, authors should replace “no effect” with “small effect”. Line 390 – Add “of” after “fear”. Lines 408-421 – If you want to compare the fearful and non-fearful groups in the same way, you need to use the same relative changes. For non-fearful subjects, you're talking only about the change between the overstated condition and the control condition, whereas for fearful subjects, you're talking about the overall relative change. So, there's a big difference between the two groups. Lines 426-427 – I would add “neck” before “pain-free range of motion” and specify that it is about rotation only. Sometimes you write “pain-free range of motion”, sometimes “cervical pain-free range of motion” and sometimes “neck pain-free range of motion”. Try to be consistent so that things are always written in the same way. In addition, I would clarify the population again. For example, the new sentence would be: “This experiment supports the view that neck pain-free range of motion in rotation can be influenced by visual perception of the amount of rotation, in people with non-specific neck pain”. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Visual feedback manipulation in virtual reality to influence pain-free range of motion. Are people with non-specific neck pain who are fearful of movement more susceptible? PONE-D-22-28987R2 Dear Dr. Maaike Kragting, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mariella Pazzaglia Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-22-28987R2 Visual feedback manipulation in virtual reality to influence pain-free range of motion. Are people with non-specific neck pain who are fearful of movement more susceptible? Dear Dr. Coppieters: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mariella Pazzaglia Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .